{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:56:15Z","timestamp":1792637775043,"version":"4.5.0"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012131","name":"Department of Science and Technology of Liaoning Province","doi-asserted-by":"publisher","award":["2024JH2\/102600340"],"award-info":[{"award-number":["2024JH2\/102600340"]}],"id":[{"id":"10.13039\/501100012131","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.colsurfb.2026.115448","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T07:47:05Z","timestamp":1768376825000},"page":"115448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Hyaluronic acid-based strategies for prostate cancer therapy"],"prefix":"10.1016","volume":"261","author":[{"given":"Xueling","family":"Lan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunhua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyi","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3786-8458","authenticated-orcid":false,"given":"Liqun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.colsurfb.2026.115448_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA a cancer journal clinicians"},{"key":"10.1016\/j.colsurfb.2026.115448_bib2","unstructured":"International Agency for Research on Cancer Global Cancer Observatory. Accessed August 22, 2022."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115448_bib3","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA a cancer journal clinicians"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115448_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","article-title":"Recent global patterns in prostate cancer incidence and mortality rates","volume":"77","author":"Culp","year":"2020","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115448_bib5","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2279235","article-title":"Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy","volume":"55","author":"Ge","year":"2023","journal-title":"Ann. Med."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115448_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s43856-022-00126-3","article-title":"Predicting biochemical recurrence of prostate cancer with artificial intelligence","volume":"2","author":"Pinckaers","year":"2022","journal-title":"Commun. Med."},{"key":"10.1016\/j.colsurfb.2026.115448_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1006101","article-title":"Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer","volume":"13","author":"Harris","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.colsurfb.2026.115448_bib8","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/ijc.33247","article-title":"Site-specific metastasis: a cooperation between cancer cells and the metastatic microenvironment","volume":"148","author":"Izraely","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"15","key":"10.1016\/j.colsurfb.2026.115448_bib9","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.3390\/molecules26154429","article-title":"Advantages of hyaluronic acid and its combination with other bioactive ingredients in cosmeceuticals","volume":"26","author":"Juncan","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115448_bib10","doi-asserted-by":"crossref","first-page":"730","DOI":"10.59324\/ejtas.2024.2(2).65","article-title":"The importance of hyaluronic acid in biological systems","volume":"2","author":"Hejran","year":"2024","journal-title":"Eur. J. Theor. Appl. Sci."},{"key":"10.1016\/j.colsurfb.2026.115448_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fimmu.2016.00039","article-title":"interaction between hyaluronic acid and its receptors (CD44, RHAMM) regulates the activity of inflammation and cancer","volume":"7","author":"Naor","year":"2016","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115448_bib12","article-title":"Functional organization of extracellular hyaluronan, CD44, and RHAMM","volume":"1","author":"Cowman","year":"2023","journal-title":"Prote Res."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115448_bib13","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/pharmaceutics14040838","article-title":"Hyaluronic acid: known for almost a century, but still in vogue","volume":"14","author":"Lierova","year":"2022","journal-title":"Pharmaceutics"},{"issue":"17","key":"10.1016\/j.colsurfb.2026.115448_bib14","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.3390\/polym14173442","article-title":"Hyaluronic acid: A review of the drug delivery capabilities of this naturally occurring polysaccharide","volume":"14","author":"Buckley","year":"2022","journal-title":"Polymers"},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115448_bib15","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.3390\/cancers16101907","article-title":"Hyaluronic acid interacting molecules mediated crosstalk between cancer cells and microenvironment from primary tumour to distant metastasis","volume":"16","author":"Xu","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.colsurfb.2026.115448_bib16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jconrel.2018.04.015","article-title":"Hyaluronic acid-based biopharmaceutical delivery and tumor-targeted drug delivery system","volume":"278","author":"Huang","year":"2018","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.colsurfb.2026.115448_bib17","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0959-8049(00)00448-2","article-title":"High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer","volume":"37","author":"Lipponen","year":"2001","journal-title":"Eur. J. Cancer"},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115448_bib18","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.3390\/pharmaceutics14102092","article-title":"Hyaluronic acid-based nanomaterials applied to cancer: where are we now?","volume":"14","author":"Machado","year":"2022","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115448_bib19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.34172\/apb.2021.050","article-title":"Understanding hyaluronan receptor (CD44) interaction, HA-CD44 activated potential targets in cancer therapeutics","volume":"11","author":"Akim","year":"2020","journal-title":"Adv. Pharm. Bull."},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115448_bib20","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3390\/biom11101518","article-title":"Hyaluronic acid: a key ingredient in the therapy of inflammation","volume":"11","author":"Marinho","year":"2021","journal-title":"Biomolecules"},{"issue":"15","key":"10.1016\/j.colsurfb.2026.115448_bib21","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1111\/febs.14777","article-title":"Hyaluronan: molecular size-dependent signaling and biological functions in inflammation and cancer","volume":"286","author":"Tavianatou","year":"2019","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115448_bib22","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1186\/1471-2407-10-512","article-title":"Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma","volume":"10","author":"Nykopp","year":"2010","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.colsurfb.2026.115448_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e19112","article-title":"Pan-cancer analysis reveals the potential of hyaluronate synthase as therapeutic targets in human tumors","volume":"9","author":"Bao","year":"2023","journal-title":"Heliyon"},{"issue":"11","key":"10.1016\/j.colsurfb.2026.115448_bib24","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3390\/cimb47110913","article-title":"MiR-10a as a Potential Biomarker and Therapeutic Target in Localized and Metastatic Prostate Cancer[J]","volume":"47","author":"Borelli Bovo","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"issue":"12","key":"10.1016\/j.colsurfb.2026.115448_bib25","doi-asserted-by":"crossref","first-page":"10050","DOI":"10.1074\/jbc.M110069200","article-title":"Manipulation of hyaluronan synthase expression in prostate adenocarcinoma cells alters pericellular matrix retention and adhesion to bone marrow endothelial cells","volume":"277","author":"Simpson","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115448_bib26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2353\/ajpath.2006.060032","article-title":"Concurrent expression of hyaluronan biosynthetic and processing enzymes promotes growth and vascularization of prostate tumors in mice","volume":"169","author":"Simpson","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"28","key":"10.1016\/j.colsurfb.2026.115448_bib27","doi-asserted-by":"crossref","first-page":"20561","DOI":"10.1074\/jbc.M702964200","article-title":"Inducible hyaluronan production reveals differential effects on prostate tumor cell growth and tumor angiogenesis","volume":"282","author":"Bharadwaj","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.colsurfb.2026.115448_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202300168","article-title":"Hyaluronan Metabolism in Urologic Cancers[J]","volume":"7","author":"Donelan","year":"2023","journal-title":"Adv. Biol."},{"issue":"15","key":"10.1016\/j.colsurfb.2026.115448_bib29","doi-asserted-by":"crossref","first-page":"11922","DOI":"10.1074\/jbc.M008432200","article-title":"Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer","volume":"276","author":"Lokeshwar","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115448_bib30","first-page":"651","article-title":"Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression","volume":"56","author":"Lokeshwar","year":"1996","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115448_bib31","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2353\/ajpath.2006.060324","article-title":"Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model","volume":"169","author":"Kovar","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.colsurfb.2026.115448_bib32","doi-asserted-by":"crossref","unstructured":"Xu Y, Lin J, Wu F, et al. Bioinformatics analysis and validation of CD44 and associated biomarkers in prostate cancer[J]. 2025, available at Research Square [https:\/\/doi.org\/10.21203\/rs.3.rs-7019627\/v1].","DOI":"10.21203\/rs.3.rs-7019627\/v1"},{"issue":"12","key":"10.1016\/j.colsurfb.2026.115448_bib33","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3390\/biom11121850","article-title":"CD44: a multifunctional mediator of cancer progression","volume":"11","author":"Hassn Mesrati","year":"2021","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115448_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-018-0605-5","article-title":"The biology and role of CD44 in cancer progression: therapeutic implications","volume":"11","author":"Chen","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.colsurfb.2026.115448_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202118","article-title":"Hyaluronan receptors as mediators and modulators of the tumor microenvironment[J]","volume":"12","author":"Carvalho","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"11","key":"10.1016\/j.colsurfb.2026.115448_bib36","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.3390\/ijms26115132","article-title":"Hyaluronan: An Architect and Integrator for Cancer and Neural Diseases[J]","volume":"26","author":"Hsu","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.colsurfb.2026.115448_bib37","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3390\/cells10082061","article-title":"Hyaluronan and its receptors: key mediators of immune cell entry and trafficking in the lymphatic system","volume":"10","author":"Johnson","year":"2021","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.colsurfb.2026.115448_bib38","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3390\/biom10111525","article-title":"Hyaluronan: metabolism and function","volume":"10","author":"Kobayashi","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.colsurfb.2026.115448_bib39","series-title":"Seminars in immunopathology","first-page":"15","article-title":"Role of Hyaluronic acid and its chemical derivatives in immunity during homeostasis, cancer and tissue regeneration[C]","author":"Rosales","year":"2024"},{"key":"10.1016\/j.colsurfb.2026.115448_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.137125","article-title":"Hyaluronan size and concentration: Effect on key biophysical and biochemical features[J]","volume":"282","author":"Di Meo","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.colsurfb.2026.115448_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.971278","article-title":"Deregulated hyaluronan metabolism in the tumor microenvironment drives cancer inflammation and tumor-associated immune suppression[J]","volume":"13","author":"Donelan","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115448_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00432-016-2213-5","article-title":"Hyaluronic acid in digestive cancers","volume":"143","author":"Wu","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.colsurfb.2026.115448_bib43","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/cancers10120482","article-title":"Differing roles of hyaluronan molecular weight on cancer cell behavior and chemotherapy resistance","volume":"10","author":"Price","year":"2018","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115448_bib44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00418-017-1559-3","article-title":"Low molecular weight hyaluronan induces migration of human choriocarcinoma JEG-3 cells mediated by RHAMM as well as by PI3K and MAPK pathways","volume":"148","author":"Mascar\u00f3","year":"2017","journal-title":"Histochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115448_bib45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/ijms24010103","article-title":"Hyaluronic acid as a modern approach in anticancer therapy-review[J]","volume":"24","author":"Michalczyk","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115448_bib46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.21873\/cgp.20375","article-title":"Receptor for hyaluronic acid-mediated motility (RHAMM) is associated with prostate cancer migration and poor prognosis","volume":"20","author":"Minato","year":"2023","journal-title":"Cancer Genom. Proteom."},{"key":"10.1016\/j.colsurfb.2026.115448_bib47","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/B978-012374178-3.10012-2","article-title":"Hyaluronidases in cancer biology","author":"Stern","year":"2008","journal-title":"Hyaluronan Cancer Biol."},{"issue":"14","key":"10.1016\/j.colsurfb.2026.115448_bib48","doi-asserted-by":"crossref","first-page":"11774","DOI":"10.3390\/ijms241411774","article-title":"CD44 modulates cell migration and invasion in Ewing sarcoma cells[J]","volume":"24","author":"Fern\u00e1ndez-Tabanera","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.colsurfb.2026.115448_bib49","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1593\/neo.09694","article-title":"RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer disease","volume":"11","author":"Gust","year":"2009","journal-title":"Neoplasia"},{"issue":"18_suppl","key":"10.1016\/j.colsurfb.2026.115448_bib50","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2007.25.18_suppl.5129","article-title":"RHAMM (CD168) is overexpressed on the protein level and may constitute an immunogenic antigen in advanced prostate cancer disease","volume":"25","author":"Ringhoffer","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115448_bib51","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2353\/ajpath.2009.080501","article-title":"Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing","volume":"174","author":"Bharadwaj","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115448_bib52","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.juro.2009.06.070","article-title":"Hyaluronic acid and HYAL-1 in prostate biopsy specimens: predictors of biochemical recurrence","volume":"182","author":"Gomez","year":"2009","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.colsurfb.2026.115448_bib53","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1158\/0008-5472.CAN-04-2805","article-title":"HYAL1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion","volume":"65","author":"Lokeshwar","year":"2005","journal-title":"Cancer Res."},{"issue":"17","key":"10.1016\/j.colsurfb.2026.115448_bib54","doi-asserted-by":"crossref","first-page":"7782","DOI":"10.1158\/0008-5472.CAN-05-1022","article-title":"HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor","volume":"65","author":"Lokeshwar","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.colsurfb.2026.115448_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102649","article-title":"The HYAL1 paradox in cancer: From complex tumor biology to novel therapeutic strategies[J]","volume":"64","author":"Jin","year":"2026","journal-title":"Transl. Oncol."},{"issue":"30","key":"10.1016\/j.colsurfb.2026.115448_bib56","doi-asserted-by":"crossref","first-page":"6076","DOI":"10.1016\/j.biomaterials.2009.07.054","article-title":"Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells","volume":"30","author":"Gurski","year":"2009","journal-title":"Biomaterials"},{"issue":"14","key":"10.1016\/j.colsurfb.2026.115448_bib57","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1080\/09205063.2017.1338502","article-title":"Three-dimensional prostate tumor model based on a hyaluronic acid-alginate hydrogel for evaluation of anti-cancer drug efficacy","volume":"28","author":"Tang","year":"2017","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"42","key":"10.1016\/j.colsurfb.2026.115448_bib58","doi-asserted-by":"crossref","first-page":"9718","DOI":"10.1039\/D0TB01570A","article-title":"Material properties of disulfide-crosslinked hyaluronic acid hydrogels influence prostate cancer cell growth and metabolism","volume":"8","author":"Tam","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.colsurfb.2026.115448_bib59","first-page":"53","article-title":"Evaluation of hyaluronic acid gel dissolution with hyaluronidase in an in-vitro prostate cancer model","volume":"33","author":"Vanneste","year":"2022","journal-title":"Clin. Transl. Radiat. Oncol."},{"issue":"11","key":"10.1016\/j.colsurfb.2026.115448_bib60","doi-asserted-by":"crossref","first-page":"e50075","DOI":"10.1371\/journal.pone.0050075","article-title":"Hyaluronan (HA) interacting proteins RHAMM and hyaluronidase impact prostate cancer cell behavior and invadopodia formation in 3D HA-based hydrogels","volume":"7","author":"Gurski","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.colsurfb.2026.115448_bib61","series-title":"Development of a Hydrogel Based Prostate Tumor Model for Cancer Cell Migration Studies[D]","author":"Demirkaya","year":"2022"},{"issue":"6","key":"10.1016\/j.colsurfb.2026.115448_bib62","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1021\/acs.molpharmaceut.9b00083","article-title":"Evaluating the efficiency of hyaluronic acid for tumor targeting via CD44","volume":"16","author":"Spadea","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2026.115448_bib63","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.colsurfb.2014.06.065","article-title":"cis-Dichlorodiamminoplatinum (II) glyconanoparticles by drug-induced ionic gelation technique targeted to prostate cancer: preparation, optimization and in vitro characterization","volume":"122","author":"Malek","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2026.115448_bib64","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.2147\/DDDT.S366622","article-title":"Prostate cancer therapy using docetaxel and formononetin combination: hyaluronic acid and epidermal growth factor receptor targeted peptide dual ligands modified binary nanoparticles to facilitate the in vivo anti-tumor activity","author":"Dong","year":"2022","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.colsurfb.2026.115448_bib65","article-title":"Formulation of surface-functionalized hyaluronic acid-coated thiolated chitosan nano-formulation for the delivery of vincristine in prostate cancer: A multifunctional targeted drug delivery approach","volume":"74","author":"Naseer","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.colsurfb.2026.115448_bib66","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.2147\/DDDT.S306684","article-title":"Combination therapy of metastatic castration-recurrent prostate cancer: hyaluronic acid decorated, cabazitaxel-prodrug and orlistat co-loaded nano-system","author":"Qu","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115448_bib67","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.carbpol.2011.04.082","article-title":"Paclitaxel loaded electrospun porous nanofibers as mat potential application for chemotherapy against prostate cancer","volume":"86","author":"Ma","year":"2011","journal-title":"Carbohydr. Polym."},{"issue":"6","key":"10.1016\/j.colsurfb.2026.115448_bib68","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.7150\/thno.18340","article-title":"Redox responsive hyaluronic acid nanogels for treating RHAMM (CD168) over-expressive cancer, both primary and metastatic tumors","volume":"7","author":"Yang","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.colsurfb.2026.115448_bib69","series-title":"Journal of Physics: Conference Series","article-title":"Cytotoxicity of hyaluronic acid coated chitosan nanoparticles containing nitric oxide donor against cancer cell lines[C]","author":"Pelegrino","year":"2019"},{"issue":"45","key":"10.1016\/j.colsurfb.2026.115448_bib70","doi-asserted-by":"crossref","first-page":"30722","DOI":"10.1021\/acsami.6b10029","article-title":"Nanoparticle targeting CD44-positive cancer cells for site-specific drug delivery in prostate cancer therapy","volume":"8","author":"Huang","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"45","key":"10.1016\/j.colsurfb.2026.115448_bib71","doi-asserted-by":"crossref","first-page":"10416","DOI":"10.1039\/D0TB01733G","article-title":"Multifunctional nanoparticles for targeting the tumor microenvironment to improve synergistic drug combinations and cancer treatment effects","volume":"8","author":"Chen","year":"2020","journal-title":"J. Mater. Chem. B"},{"issue":"27","key":"10.1016\/j.colsurfb.2026.115448_bib72","doi-asserted-by":"crossref","first-page":"23880","DOI":"10.1021\/acsami.9b06155","article-title":"Co-delivery of natural compounds with a dual-targeted nanoparticle delivery system for improving synergistic therapy in an orthotopic tumor model","volume":"11","author":"Chu","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115448_bib73","doi-asserted-by":"crossref","first-page":"160","DOI":"10.15430\/JCP.2023.28.4.160","article-title":"Potent suppression of prostate cancer cell growth and eradication of cancer stem cells by CD44-targeted nanoliposome-quercetin nanoparticles","volume":"28","author":"Turkekul","year":"2023","journal-title":"J. Cancer Prev."},{"key":"10.1016\/j.colsurfb.2026.115448_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112475","article-title":"Double-responsive hyaluronic acid-based prodrugs for efficient tumour targeting","volume":"131","author":"Quagliariello","year":"2021","journal-title":"Materials Science Engineering C"},{"key":"10.1016\/j.colsurfb.2026.115448_bib75","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2147\/IJN.S444815","article-title":"Targeted delivery of geraniol via hyaluronic acid-conjugation enhances its anti-tumor activity against prostate cancer","author":"Yu","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2026.115448_bib76","first-page":"1","article-title":"Anti-proliferative and anti-migratory effects of Urtica dioica agglutinin loaded chitosan nanoparticles with hyaluronic acid coating on the CD44-overexpressing prostate cancer cells","author":"Heydari","year":"2025","journal-title":"Int. J. Environ. Health Res."},{"issue":"12","key":"10.1016\/j.colsurfb.2026.115448_bib77","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1039\/C7RA12969F","article-title":"Fabrication of a hyaluronic acid conjugated metal organic framework for targeted drug delivery and magnetic resonance imaging","volume":"8","author":"Shu","year":"2018","journal-title":"RSC Adv."},{"issue":"21","key":"10.1016\/j.colsurfb.2026.115448_bib78","doi-asserted-by":"crossref","first-page":"25339","DOI":"10.1021\/acsami.3c02647","article-title":"Biodegradable imprinted polymer based on ZIF-8\/DOX-HA for synergistically targeting prostate cancer cells and controlled drug release with multiple responses","volume":"15","author":"Song","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.colsurfb.2026.115448_bib79","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.actbio.2022.01.012","article-title":"Tumor microenvironment pH-responsive pentagonal gold prism-based nanoplatform for multimodal imaging and combined therapy of castration-resistant prostate cancer","volume":"141","author":"Tan","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.colsurfb.2026.115448_bib80","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.biomaterials.2015.08.048","article-title":"Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells","volume":"72","author":"Wang","year":"2015","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.colsurfb.2026.115448_bib81","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202412244","article-title":"Combined blockade of lipid uptake and synthesis by CD36 inhibitor and SCD1 siRNA is beneficial for the treatment of refractory prostate cancer","volume":"12","author":"Chen","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.colsurfb.2026.115448_bib82","article-title":"Hyaluronic Acid Nanoparticles-encapsulated Bacterial Genotoxin for Targeted Therapy of Radioresistant Prostate Cancer","author":"Chen","year":"2020","journal-title":"Res. Sq."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115448_bib83","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/nano11010144","article-title":"Development of a new hyaluronic acid based redox-responsive nanohydrogel for the encapsulation of oncolytic viruses for cancer immunotherapy","volume":"11","author":"Deng","year":"2021","journal-title":"Nanomaterials"},{"issue":"7","key":"10.1016\/j.colsurfb.2026.115448_bib84","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29748","article-title":"Co-delivery of oncolytic virus and chemotherapeutic modality: Vincristine against prostate cancer treatment: A potent viro-chemotherapeutic approach","volume":"96","author":"Anjum","year":"2024","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.colsurfb.2026.115448_bib85","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.actbio.2018.06.016","article-title":"Hyaluronic acid formulation of near infrared fluorophores optimizes surgical imaging in a prostate tumor xenograft","volume":"75","author":"Souchek","year":"2018","journal-title":"Acta Biomater."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115448_bib86","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1021\/cr050247k","article-title":"Hyaluronidases: their genomics, structures, and mechanisms of action","volume":"106","author":"Stern","year":"2006","journal-title":"Chem. Rev."},{"key":"10.1016\/j.colsurfb.2026.115448_bib87","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.carbpol.2015.07.029","article-title":"Influence of tiopronin, captopril and levamisole therapeutics on the oxidative degradation of hyaluronan","volume":"134","author":"Valachov\u00e1","year":"2015","journal-title":"Carbohydr. Polym."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115448_bib88","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3390\/antiox12040824","article-title":"Hyaluronan and reactive oxygen species signaling\u2014novel cues from the matrix?[J]","volume":"12","author":"Berdiaki","year":"2023","journal-title":"Antioxidants"},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115448_bib89","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1042\/bj2000415","article-title":"Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit","volume":"200","author":"Fraser","year":"1981","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115448_bib90","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/pro6.1129","article-title":"Guidelines for radiotherapy of prostate cancer (2020 edition)","volume":"5","author":"Li","year":"2021","journal-title":"Precis. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115448_bib91","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijrobp.2007.02.034","article-title":"Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients","volume":"69","author":"Prada","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115448_bib92","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1590\/S1677-5538.IBJU.2014.0531","article-title":"Low-dose-rate brachytherapy for patients with transurethral resection before implantation in prostate cancer. Long-term results","volume":"42","author":"Prada","year":"2016","journal-title":"Int. Braz. J. Urol."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115448_bib93","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00066-017-1238-2","article-title":"Long-term outcomes in patients younger than 60 years of age treated with brachytherapy for prostate cancer","volume":"194","author":"Prada","year":"2018","journal-title":"Strahlenther. und Onkol."},{"issue":"5","key":"10.1016\/j.colsurfb.2026.115448_bib94","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3390\/biomedicines10050959","article-title":"Intraoperative Neurovascular Bundle Preservation with Hyaluronic Acid during Radical Brachytherapy for Localized Prostate Cancer: Technique and MicroMosfet In Vivo Dosimetry","volume":"10","author":"Prada","year":"2022","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115448_bib95","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.brachy.2008.11.010","article-title":"Transperineal injection of hyaluronic acid in the anterior perirectal fat to decrease rectal toxicity from radiation delivered with low-dose-rate brachytherapy for prostate cancer patients","volume":"8","author":"Prada","year":"2009","journal-title":"Brachytherapy"},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115448_bib96","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.brachy.2011.05.003","article-title":"High-dose-rate interstitial brachytherapy as monotherapy in one fraction and transperineal hyaluronic acid injection into the perirectal fat for the treatment of favorable stage prostate cancer: treatment description and preliminary results","volume":"11","author":"Prada","year":"2012","journal-title":"Brachytherapy"},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115448_bib97","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.radonc.2016.04.006","article-title":"High-dose-rate interstitial brachytherapy as monotherapy in one fraction for the treatment of favorable stage prostate cancer: Toxicity and long-term biochemical results","volume":"119","author":"Prada","year":"2016","journal-title":"Radiother. Oncol."},{"issue":"6","key":"10.1016\/j.colsurfb.2026.115448_bib98","doi-asserted-by":"crossref","first-page":"605","DOI":"10.5114\/jcb.2021.112110","article-title":"Impact of hydrogel and hyaluronic acid rectal spacer on rectal dosimetry and toxicity in LDR prostate brachytherapy: a multi-institutional analysis of patients' outcomes","volume":"13","author":"Lin","year":"2021","journal-title":"J. Contemp. Brachytherapy"},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115448_bib99","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ajur.2022.08.006","article-title":"A preliminary study on rectal dose reduction associated with hyaluronic acid implantation in brachytherapy for prostate cancer","volume":"11","author":"Kashihara","year":"2024","journal-title":"Asian J. Urol."},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115448_bib100","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1016\/j.ijrobp.2024.07.2279","article-title":"Assessing the Feasibility and Dosimetric Impact of a Non-Animal Stabilized Hyaluronic Acid (NASHA) Rectal Spacer in High-Dose-Rate Brachytherapy for Prostate Cancer","volume":"120","author":"Patel","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115448_bib101","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijrobp.2012.11.027","article-title":"Prostate hypofractionated radiation therapy: injection of hyaluronic acid to better preserve the rectal wall","volume":"86","author":"Chapet","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115448_bib102","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijrobp.2013.10.039","article-title":"Dosimetric implications of an injection of hyaluronic acid for preserving the rectal wall in prostate stereotactic body radiation therapy","volume":"88","author":"Chapet","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115448_bib103","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ijrobp.2014.11.027","article-title":"Prostate hypofractionated radiation therapy with injection of hyaluronic acid: acute toxicities in a phase 2 study","volume":"91","author":"Chapet","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1124","key":"10.1016\/j.colsurfb.2026.115448_bib104","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210242","article-title":"Prostate hypofractionated radiotherapy (62Gy at 3.1 Gy per fraction) with injection of hyaluronic acid: final results of the RPAH1 study","volume":"94","author":"Chapet","year":"2021","journal-title":"Br. J. Radiol."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115448_bib105","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/jamaoncol.2022.7592","article-title":"Hyaluronic acid spacer for hypofractionated prostate radiation therapy: a randomized clinical trial","volume":"9","author":"Mariados","year":"2023","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115448_bib106","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1016\/j.ijrobp.2022.07.1173","article-title":"The Use of HA as Rectal Spacer in Prostate Cancer Patients Undergoing Hypofractionated RT: An Australian Experience","volume":"114","author":"Holt","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115448_bib107","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.brachy.2011.06.006","article-title":"Reirradiation of prostate cancer with rectum preservation: Eradicative high-dose-rate brachytherapy with natural type hyaluronate injection","volume":"11","author":"Kishi","year":"2012","journal-title":"Brachytherapy"},{"issue":"8","key":"10.1016\/j.colsurfb.2026.115448_bib108","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.canrad.2020.03.009","article-title":"Hyaluronic acid spacer in focal prostate reirradiation: A single centre experience","volume":"24","author":"Ozyigit","year":"2020","journal-title":"Cancer\/Radio. \u00e9rapie"},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115448_bib109","doi-asserted-by":"crossref","first-page":"e560","DOI":"10.1016\/j.ijrobp.2024.07.1240","article-title":"Hyaluronic Acid Rectal Spacer in Locally Recurrent Prostate Cancer with Prior Radiation Receiving SBRT: A Report on Feasibility, Safety and Toxicity","volume":"120","author":"McLean","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.colsurfb.2026.115448_bib110","article-title":"Association of perirectal hydrogel spacer placement with clinical outcomes in patients with prostate cancer undergoing radiotherapy: A systematic review and meta-analysis[J]","volume":"43","author":"Kwon","year":"2025","journal-title":"World J. Men. 's. Health"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115448_bib111","doi-asserted-by":"crossref","DOI":"10.1089\/vid.2023.0003","article-title":"Hyaluronic Acid as a Tissue Spacer Between Prostate and Rectum to Aid Dissection During Radical Prostatectomy","volume":"37","author":"Tempo","year":"2023","journal-title":"Videourology"},{"issue":"7","key":"10.1016\/j.colsurfb.2026.115448_bib112","article-title":"Synchronous insertion of hyaluronic acid-based biodegradable rectal spacer for primary prostate cryotherapy","volume":"2","author":"Parr","year":"2024","journal-title":"JU Open"},{"key":"10.1016\/j.colsurfb.2026.115448_bib113","first-page":"1308","article-title":"Simulation of thermal effects on rectal wall during laser treatment of prostate cancer using hyaluronic acid and polyethylene glycol spacers: a generalized dual-phase-lag bioheat approach","volume":"33","author":"Boontatao","year":"2024","journal-title":"Eng. Sci."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115448_bib114","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2009.05.069","article-title":"Cross-linked hyaluronan gel reduces the acute rectal toxicity of radiotherapy for prostate cancer","volume":"77","author":"Wilder","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115448_bib115","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brachy.2009.12.005","article-title":"Cross-linked hyaluronan gel improves the quality of life of prostate cancer patients undergoing radiotherapy","volume":"10","author":"Wilder","year":"2011","journal-title":"Brachytherapy"},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115448_bib116","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.1016\/j.ijrobp.2023.06.1574","article-title":"Hyaluronic Acid Rectal Spacer Stability during Radiation Therapy for Localized Prostate Cancer: An Intercontinental Study","volume":"117","author":"Moreno-Olmedo","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115448_bib117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-022-02197-x","article-title":"Hyaluronic acid spacer in prostate cancer radiotherapy: dosimetric effects, spacer stability and long-term toxicity and PRO in a phase II study","volume":"18","author":"Bj\u00f6reland","year":"2023","journal-title":"Radiat. Oncol."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115448_bib118","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jmir.2022.09.008","article-title":"Hyaluronic acid rectal spacer in EBRT: Usability, safety and symmetry related to user experience","volume":"53","author":"Williams","year":"2022","journal-title":"J. Med. Imaging Radiat. Sci."},{"issue":"9","key":"10.1016\/j.colsurfb.2026.115448_bib119","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1002\/mp.17292","article-title":"Symmetry, separation, and stability: Physical properties for effective dosimetric space with a stabilized hyaluronic acid spacer","volume":"51","author":"Svatos","year":"2024","journal-title":"Med. Phys."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526000366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526000366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:07:54Z","timestamp":1773958074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776526000366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":119,"alternative-id":["S0927776526000366"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.115448","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyaluronic acid-based strategies for prostate cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.115448","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115448"}}